LLLi Li

Li Li

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Li Li has a total of 11 co-authors. Here are the top co-authors by number of shared publications:

  • Yuan-Yu Wang

    General Surgery, Cancer Center, Department of Gastrointestinal and Pancreatic Surgery, Zhejiang Provincial People’s Hospital (Affiliated People’s Hospital, Hangzhou Medical College), Hangzhou, China

    3 shared publications
  • Hui-Ju Wang

    General Surgery, Cancer Center, Department of Gastrointestinal and Pancreatic Surgery, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, China

    2 shared publications
  • Hui Wang

    Department of Ultrasound, Taian Maternal and Child Health Hospital, Taian 310014, Shandong Province, China

    1 shared publication
  • Hui-Ju Wang

    Key Laboratory of Gastroenterology of Zhejiang Province, 158 shangtang road, Hangzhou, Zhejiang, 310014, PR China

    1 shared publication
  • Lei Wang

    Department of Gastrointestinal Surgery, Central Hospital Affiliated to Shandong First Medical University, Jinan, China

    1 shared publication
  • Li-Li Ge

    Department of Nursing,Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, China

    1 shared publication

Latest Publications

  • Open Access

    Da-yuan-yin decoction ameliorates inflammatory injury in severe pancreatitis by protecting intestinal mucosal barrier and immune function and preventing intestinal dysbiosis

    by Yi-Hong Zhang, Lei Wang, Li Li, Yuan-Yu Wang

    Introduction: Acute pancreatitis (AP) is a common gastrointestinal condition characterized by inflammation of the pancreas. AP treatment is highly challenging due to the long hospital stays, higher medical expenses, and multiple complications. Traditional Chinese medicine has been used in China for thousands of years and is clinically proven to be a safe and effective treatment strategy for pancreatitis. Methods: To investigate whether a da-yuan-yin (DYY) decoction ameliorates inflammatory injury in severe pancreatitis. The severe acute pancreatitis (SAP) model was established by retrograde injection of 5% sodium taurocholate into the bile duct of male Sprague–Dawley rats. We detected the intestinal mucosal barrier function and intestinal immune function, and analyzed the changes of gut flora using the 16S rRNA gene testing. Results: Cell damage was more serious in SAP than that of DYY + SAP. The expression of myeloperoxidase and EGF-like module-containing mucin-like hormone receptor-like 1 in SAP was significantly higher than in DYY + SAP. Serum endotoxin, d -lactate, intestinal fatty acid-binding protein, interleukin (IL)-1β, and IL-10 of SAP and DYY + SAP were significantly increased. Plasma vasoactive intestinal peptide (VIP) was significantly reduced in both SAP and DYY + SAP; plasma VIP in DYY + SAP was significantly lower than in SAP. Levels of CD3 + , CD4 + , and CD8 + cells from ileal Peyer’s patches in SAP and DYY + SAP were decreased; the levels of CD3 + , CD4 + , and CD8 + cells of DYY + SAP were significantly higher than in SAP. Species difference analysis showed significant differences among the top 10 most relatively abundant species in the sham operation (SO), SAP, and DYY + SAP at each taxonomic level (phylum, class, order, family, and genus). Clustered heat map analysis showed differences in species at the genus level among the SO, SAP, and DYY + SAP. At the phylum level, there were differences in the expression levels of proteobacteria and bactroidota between the SO and SAP, but not among other groups. Conclusion: The DYY decoction may reduce tissue injury, protect the intestinal mucosal barrier, enhance intestinal immune function, and help prevent intestinal dysbiosis in ascitic fluid and stool specimens.

  • Open Access

    Lycorine inhibits migration and proliferation of hepatocellular carcinoma cells by reducing transketonase expression

    by Li-Li Ge, Hui Wang, Yi-Hong Zhang, Hui-Ju Wang, Li Li

    Background: Previous studies have showed that lycorine can restrain the development of multiple tumor types, containing hepatocellular carcinoma (HCC), but the underlying mechanisms remain unknown.


  • Open Access

    VSNL1 Promotes Gastric Cancer Cell Proliferation and Migration by Regulating P2X3/P2Y2 Receptors and Is a Clinical Indicator of Poor Prognosis in Gastric Cancer Patients

    by Qiao-Qiong Dai, Yuan-Yu Wang, Yu-Peng Jiang, Li Li, Hui-Ju Wang

    Purpose. The aim of this study was to investigate the role of Visinin Like 1 (VSNL1) in the proliferation and migration of gastric cancer (GC) cells as well as its clinical prognostic significance. Methods. To this end, we evaluated VSNL1 expression in GC tissues and cell lines by real-time PCR and immunohistochemistry. To further explore the effects of VSNL1, a lentiviral vector expressing a short hairpin RNA (shRNA) against VSNL1 was constructed and transduced into the GC cell lines BGC-823 and SGC-7901. The interference efficiency of VSNL1-shRNA was determined by western blot. The effects of VSNL1 on the migration and invasion of GC cells as well as the expression of P2X3/P2Y2 were explored using MTS, colony formation, migration, and western blot assays. Results. VSNL1 mRNA and protein levels were increased in GC tissues and cell lines. Furthermore, VSNL1 expression was positively correlated with Laurens classification, lymph node metastasis, distant metastasis, TNM stage, and prognosis. VSNL1 expression was inversely correlated with the 5-year survival rate of GC patients. VSNL1 expression was markedly reduced in cells transduced with lentivirus expressing shRNA against VSNL1, and inhibiting VSNL1 expression significantly suppressed cell growth, migration, and colony formation and reduced the expression of P2X3/P2Y2. Conclusion. VSNL1 may promote the proliferation and migration of GC cells by regulating P2X3 and P2Y2 expression. VSNL1 plays important roles in GC development and metastasis and may be correlated with patient prognosis.


  • Open Access

    Clinical utility of measuring expression levels of KAP1, TIMP1 and STC2 in peripheral blood of patients with gastric cancer

    by Yuan-Yu Wang, Li Li, Zhong-Sheng Zhao, Hui-Ju Wang

    Background: We examined preoperative kinesin II-associated protein (KAP1), TIMP metallopeptidase inhibitor 1 (TIMP1) and stanniocalcin 2 (STC2) expression levels in patients with gastric cancers to assess their clinical application for diagnosing and monitoring diseases. Methods: Real-time reverse transcription-polymerase chain reaction was used to detect the expression levels of KAP1, TIMP1, STC2, talin 2 (TLN2), sushi-repeat-containing protein, X-linked 2 (SRPX2) and secreted protein, acidic, cysteine-rich (SPARC) in the patients’ peripheral blood karyocytes. The data were analyzed with receiver operating characteristics (ROC) curves. Results: A total of 112 patients with gastric cancer, 42 patients with recurrence and 107 healthy volunteers were recruited. There were significant correlations between KAP1, TIMP1 and STC2 levels, and TNM tumor stages and distant metastases. The area under the ROC curves (AUC) of KAP1 was 0.803 ± 0.040 (P = 0.0001), the AUC of TIMP1 was 0.767 ± 0.043 (P = 0.0001) and the AUC of STC2 was 0.769 ± 0.045 (P = 0.0001), thus differentiating preoperative gastric cancer patients from healthy volunteers by ROC curve analysis. The AUC of STC2 was 0.739 ± 0.070 (P = 0.004) and the AUC of KAP1 was 0.418 ± 0.088 (P = 0.319), thus differentiating recurrence of gastric cancer from healthy volunteers by ROC curve analysis. High TIMP1 and STC2 expression levels were suspected to be poor prognostic factors of disease recurrence in patients with gastric cancer. Conclusions: KAP1, TIMP1 and STC2 expression levels may be potential biomarkers for the screening, diagnosis, prognosis and surveillance of gastric cancer.